Literature DB >> 9861412

A 5 days primaquine regimen as anti-relapse therapy for Plasmodium vivax.

N Gogtay1, M Garg, V Kadam, K Kamtekar, N A Kshirsagar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9861412     DOI： 10.1016/s0035-9203(98)91034-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  5 in total

Review 1.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

2.  RADICAL CURE OF VIVAX MALARIA : 5 OR 14 DAYS.

Authors:  K M Hassan; M K Gosh
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.

Authors:  Judith Recht; Elizabeth A Ashley; Nicholas J White
Journal:  PLoS Negl Trop Dis       Date:  2018-04-19

4.  Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.

Authors:  Cindy S Chu; Aung Pyae Phyo; Claudia Turner; Htun Htun Win; Naw Pet Poe; Widi Yotyingaphiram; Suradet Thinraow; Pornpimon Wilairisak; Rattanaporn Raksapraidee; Verena I Carrara; Moo Kho Paw; Jacher Wiladphaingern; Stéphane Proux; Germana Bancone; Kanlaya Sriprawat; Sue J Lee; Atthanee Jeeyapant; James Watson; Joel Tarning; Mallika Imwong; François Nosten; Nicholas J White
Journal:  Clin Infect Dis       Date:  2019-04-08       Impact factor: 9.079

Review 5.  On the epidemiology of Plasmodium vivax malaria: past and present with special reference to the former USSR.

Authors:  Anatoly V Kondrashin; Lola F Morozova; Ekaterina V Stepanova; Natalia A Turbabina; Maria S Maksimova; Evgeny N Morozov
Journal:  Malar J       Date:  2018-10-04       Impact factor: 2.979
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.